Prof. Hendrik Tobias Arkenau

Professor Tobias Arkenau is a renowned consultant Medical Oncologist with HCA Healthcare and is practising at The LOC and The Harley Street Clinic in London. He is also serving as a Chief Medical Officer and Global Head of Drug Development at Ellipses Pharma, a London-based biotech focusing on cancer drug development.

He was a founding Medical Director of the Sarah Cannon Research Institute UK and Clinical Lead for the HCA Healthcare UK Cancer Service Line. He is holding an honorary Professorship at University College London Hospital.

Prof Arkenau has a wide range of experience in a variety of cancers, particularly gastrointestinal and skin cancers. He was awarded his medical degree from Hanover Medical School in Germany in 2000. Following this, he completed his specialist training in oncology across numerous centres of excellence, including the Royal Marsden Hospital. He was awarded a Fellowship by the Royal College of Physicians, and he is a key opinion leader in his field of Gastrointestinal Cancers, Drug Development and Immunotherapy for his research contributions to his field. During his career, he has published numerous peer-reviewed articles and book chapters and contributes regularly at international meetings such as ASCO, ESMO and AACR.